Cargando…

Modified serpinA1 as risk marker for Parkinson’s disease dementia: Analysis of baseline data

Early detection of dementia in Parkinson disease is a prerequisite for preventive therapeutic approaches. Modified serpinA1 in cerebrospinal fluid (CSF) was suggested as an early biomarker for differentiation between Parkinson patients with (PDD) or without dementia (PD). Within this study we aimed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Halbgebauer, Steffen, Nagl, Magdalena, Klafki, Hans, Haußmann, Ute, Steinacker, Petra, Oeckl, Patrick, Kassubek, Jan, Pinkhardt, Elmar, Ludolph, Albert C., Soininen, Hilkka, Herukka, Sanna-Kaisa, Wiltfang, Jens, Otto, Markus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4868992/ https://www.ncbi.nlm.nih.gov/pubmed/27184740 http://dx.doi.org/10.1038/srep26145

Ejemplares similares

CSF SerpinA1 in Creutzfeldt–Jakob disease and frontotemporal lobar degeneration
por: Abu‐Rumeileh, Samir, et al.
Publicado: (2020)

Specific Cerebrospinal Fluid SerpinA1 Isoform Pattern in Alzheimer’s Disease
por: Barba, Lorenzo, et al.
Publicado: (2022)

Differential Sialylation of Serpin A1 in the Early Diagnosis of Parkinson’s Disease Dementia
por: Jesse, Sarah, et al.
Publicado: (2012)

Visinin-like protein 1 levels in blood and CSF as emerging markers for Alzheimer’s and other neurodegenerative diseases
por: Halbgebauer, Steffen, et al.
Publicado: (2022)

In Vitro and In Vivo Effects of SerpinA1 on the Modulation of Transthyretin Proteolysis
por: Bezerra, Filipa, et al.
Publicado: (2021)

Cirrhosis of liver: Interference of serpins in quantification of SERPINA4 – A preliminary study
por: Nallagangula, Krishna Sumanth, et al.
Publicado: (2017)

Evidence for Elevated Cerebrospinal Fluid ERK1/2 Levels in Alzheimer Dementia
por: Spitzer, Philipp, et al.
Publicado: (2011)

Neuronal pentraxins as biomarkers of synaptic activity: from physiological functions to pathological changes in neurodegeneration
por: Gómez de San José, Nerea, et al.
Publicado: (2021)

Snail and serpinA1 promote tumor progression and predict prognosis in colorectal cancer
por: Kwon, Chae Hwa, et al.
Publicado: (2015)

SerpinA3N attenuates ischemic stroke injury by reducing apoptosis and neuroinflammation
por: Zhang, Yu, et al.
Publicado: (2021)

SerpinA3K Deficiency Reduces Oxidative Stress in Acute Kidney Injury
por: González-Soria, Isaac, et al.
Publicado: (2023)

Amygdala size in amyotrophic lateral sclerosis without dementia: an in vivo study using MRI volumetry
por: Pinkhardt, Elmar H, et al.
Publicado: (2006)

CSF Ubiquitin Levels Are Higher in Alzheimer’s Disease than in Frontotemporal Dementia and Reflect the Molecular Subtype in Prion Disease
por: Abu-Rumeileh, Samir, et al.
Publicado: (2020)

Saccadic intrusions in amyotrophic lateral sclerosis (ALS)
por: Becker, Wolfgang, et al.
Publicado: (2019)

Neurochemical Monitoring of Traumatic Brain Injury by the Combined Analysis of Plasma Beta-Synuclein, NfL, and GFAP in Polytraumatized Patients
por: Halbgebauer, Rebecca, et al.
Publicado: (2022)

MRI as a first-line imaging modality in acute ischemic stroke: a sustainable concept
por: Althaus, Katharina, et al.
Publicado: (2021)

Diagnostic value of video-oculography in progressive supranuclear palsy: a controlled study in 100 patients
por: Wunderlich, Jessica, et al.
Publicado: (2021)

Neurofilament light and heterogeneity of disease progression in amyotrophic lateral sclerosis: development and validation of a prediction model to improve interventional trials
por: Witzel, Simon, et al.
Publicado: (2021)

SerpinA3N deficiency deteriorates impairments of learning and memory in mice following hippocampal stab injury
por: Wang, Zhi-Meng, et al.
Publicado: (2020)

IFN-Inducible SerpinA5 Triggers Antiviral Immunity by Regulating STAT1 Phosphorylation and Nuclear Translocation
por: Wang, Congcong, et al.
Publicado: (2023)

Eye movement impairments in Parkinson's disease: possible role of extradopaminergic mechanisms
por: Pinkhardt, Elmar H, et al.
Publicado: (2012)

Acute DWI Reductions In Patients After Single Epileptic Seizures - More Common Than Assumed
por: Hübers, Annemarie, et al.
Publicado: (2018)

Alterations of Eye Movement Control in Neurodegenerative Movement Disorders
por: Gorges, Martin, et al.
Publicado: (2014)

Neurofilaments in blood and CSF for diagnosis and prediction of onset in Creutzfeldt-Jakob disease
por: Steinacker, Petra, et al.
Publicado: (2016)

The serine protease inhibitor SerpinA3N attenuates neuropathic pain by inhibiting T cell-derived leukocyte elastase
por: Vicuña, Lucas, et al.
Publicado: (2015)

SerpinA3N is a novel hypothalamic gene upregulated by a high-fat diet and leptin in mice
por: Sergi, Domenico, et al.
Publicado: (2018)

Plasma SerpinA5 in conjunction with uterine artery pulsatility index and clinical risk factor for the early prediction of preeclampsia
por: Zhang, Yonggang, et al.
Publicado: (2021)

Cognitive and Neuropsychiatric Symptom Differences in Early Stages of Alzheimer's Disease: Kuopio ALSOVA Study
por: Hallikainen, Ilona, et al.
Publicado: (2012)

Potential impact of serpin peptidase inhibitor clade (A) member 4 SERPINA4 (rs2093266) and SERPINA5 (rs1955656) genetic variants on COVID-19 induced acute kidney injury
por: El-Hefnawy, Sally M., et al.
Publicado: (2022)

Serpin peptidase inhibitor, clade A member 3 (SERPINA3), is overexpressed in glioma and associated with poor prognosis in glioma patients
por: Luo, Dingyuan, et al.
Publicado: (2017)

Solid‐Phase Synthesis and Characterization of N‐Terminally Elongated Aβ(−3–x)‐Peptides
por: Beyer, Isaak, et al.
Publicado: (2016)

Segmental Alterations of the Corpus Callosum in Progressive Supranuclear Palsy: A Multiparametric Magnetic Resonance Imaging Study
por: Bârlescu, Lavinia A., et al.
Publicado: (2021)

Predicting AD Conversion: Comparison between Prodromal AD Guidelines and Computer Assisted PredictAD Tool
por: Liu, Yawu, et al.
Publicado: (2013)

Plasma β‐synuclein, GFAP, and neurofilaments in patients with malignant gliomas undergoing surgical and adjuvant therapy
por: Abu‐Rumeileh, Samir, et al.
Publicado: (2023)

Cerebrospinal fluid levels of proenkephalin and prodynorphin are differentially altered in Huntington’s and Parkinson’s disease
por: Barschke, Peggy, et al.
Publicado: (2022)

High diagnostic performance of plasma and cerebrospinal fluid beta‐synuclein for sporadic Creutzfeldt–Jakob disease
por: Abu‐Rumeileh, Samir, et al.
Publicado: (2023)

The Cerebro-Morphological Fingerprint of a Progeroid Syndrome: White Matter Changes Correlate with Neurological Symptoms in Xeroderma Pigmentosum
por: Kassubek, Jan, et al.
Publicado: (2012)

The Chemokine CXCL13 Is a Prognostic Marker in Clinically Isolated Syndrome (CIS)
por: Brettschneider, Johannes, et al.
Publicado: (2010)

Decreased plasma C‐reactive protein levels in APOE ε4 allele carriers
por: Martiskainen, Henna, et al.
Publicado: (2018)

CSF Concentrations of cAMP and cGMP Are Lower in Patients with Creutzfeldt-Jakob Disease but Not Parkinson's Disease and Amyotrophic Lateral Sclerosis
por: Oeckl, Patrick, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_ivscdvaesrlcfd4mh3l8m46dmv